DRUG FOOD INTERACTIONS A REVIEW OF CONTEMPORARY EVIDENCE

Authors

  • Khotamova Gulnoza Komilovna Asia International University ORCID: 0009-0000-2690-1500

Keywords:

food–drug interaction; pharmacokinetics; CYP3A4; grapefruit; warfarin; chelation; patient awareness.

Abstract

Food–drug interactions can alter drug absorption, metabolism and effect, influencing the efficacy and safety of therapy, yet they remain less studied than drug–drug interactions. This narrative review summarises mechanisms, clinically relevant examples and practical recommendations reported in sources published from 2021 to 2026. We searched open-access scientific sources and selected 15 publications, including narrative, systematic and scoping reviews, cross-sectional studies, a database, regulatory guidance and a conference abstract. The evidence indicates that interactions arise mainly through altered absorption, intestinal enzyme or transporter activity, chelation with cations and pharmacodynamic effects. Grapefruit irreversibly inhibits intestinal CYP3A4, while calcium and iron can reduce fluoroquinolone and tetracycline absorption; in one hospital study, 74.5% of 47 patients receiving both an antibiotic and a cation-containing product took them at the same time. For warfarin, a consistent vitamin K intake is recommended. Most newer cardiovascular and antidiabetic medicines can be taken with or without food, although oral semaglutide is an exception. Evidence concerning phenytoin remains limited: only 3 of 12 studies in the reviewed systematic review were rated as having moderate certainty. Clinical assessment should consider a medicine’s bioavailability and metabolic pathway alongside the patient’s dietary habits. The review is narrative and its findings are limited by the breadth of the search and the variable quality of included evidence.

 

 

References

1.Lacruz-Pleguezuelos B, Piette O, Garranzo M, et al. FooDrugs: a comprehensive food–drug interactions database with text documents and transcriptional data. Database (Oxford). 2023;2023:baad075. doi:10.1093/database/baad075

2.Roy R, Marakkar S, Vayalil MP, et al. Drug-food interactions in the era of molecular big data, machine intelligence, and personalized health. Recent Adv Food Nutr Agric. 2022;13(1):27–50. doi:10.2174/2212798412666220620104809

3.Tolou-Ghamari Z. Interactions among drugs, food, beverages, alcohol, herbs, phytochemicals, nutraceuticals, and micronutrients: a current and updated review. Cardiovasc Hematol Agents Med Chem. 2026;24(2). [pages and DOI to be completed]

4.U.S. Food and Drug Administration, CDER. Assessing the effects of food on drugs in INDs and NDAs — clinical pharmacology considerations: guidance for industry, revision 1. May 2026. https://www.fda.gov/media/121313/download

5.Abu Dayyih W, Al-Ani I, Hailat M, et al. Review of grapefruit juice–drugs interactions mediated by intestinal CYP3A4 inhibition. J Appl Pharm Sci. 2024;14(05):059–068. doi:10.7324/JAPS.2024.160197

6.Eljaaly K, Helal A, Almandeel T, Algarni R, Alshehri S. Multivalent cations interactions with fluoroquinolones or tetracyclines: a cross-sectional study. Saudi J Biol Sci. 2021;28(12):6929–6932. doi:10.1016/j.sjbs.2021.07.065

7.Talasaz AH, McGonagle B, HajiQasemi M. Pharmacokinetic and pharmacodynamic interactions between food or herbal products and oral anticoagulants: evidence review, practical recommendations, and knowledge gaps. Semin Thromb Hemost. 2024. doi:10.1055/s-0044-1790258

8.Grześk G, Rogowicz D, Wołowiec Ł, et al. The clinical significance of drug–food interactions of direct oral anticoagulants. Int J Mol Sci. 2021;22(16):8531. doi:10.3390/ijms22168531

9.Food-drug interactions of novel drugs used in cardiologic and diabetic patients — a PRISMA scoping review. [authors and journal to be completed]. PMID: 42124949

10.[Authors]. The impact of dietary interventions on the pharmacokinetics of antifungal drugs: a systematic review with meta-analyses. Clin Pharmacokinet. 2025. doi:10.1007/s40262-025-01511-6. PMID: 40347349

11.Orellana-Paucar AM, Mosquera-Lopez ET, Bustamante-Alvarez NM, et al. Optimizing phenytoin therapy: a systematic review of clinically relevant food and herb interactions. Front Pharmacol. 2026;16:1676685. doi:10.3389/fphar.2025.1676685

12.Washington K, et al. Levothyroxine sodium oral solution administered with coffee versus fasting: bioavailability study [conference abstract; verify full title]. ENDO 2022, Endocrine Society annual meeting, Atlanta, 11–14 June 2022. Reported by: HealthDay News, 17 June 2022 (Endo: coffee doesn't mar bioavailability of levothyroxine solution).

13.Kuźbicka K, Pawłowska I, Pawłowski L, Kocić I. Awareness and knowledge of drug-drug and food-drug interactions among adults in Poland — a questionnaire-based survey. Eur J Transl Clin Med. 2024;7(2):40–49.

14.Megaw C, Olivier N, Cordier W. South African dietitians' knowledge and perceptions of food-drug interactions and factors affecting it. J Hum Nutr Diet. 2025. doi:10.1111/jhn.70010

15.Saleh MA, Mohammed SS. Knowledge, awareness, and attitudes toward food–drug interactions among a sample of the Iraqi population in Baghdad: a cross-sectional study. J Nutr Food Secur. 2026;11(3):386–392.

Published

2026-11-02